Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Cabozantinib in Combination With Pemetrexed in Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC), Urothelial Cancer and Advanced Malignant Mesothelioma

NCT04173338 is registered in ClinicalTrials.gov with Augusta University as lead sponsor.

NCT NCT04173338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04173338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Cabozantinib in Combination With Pemetrexed in Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC), Urothelial Cancer and Advanced Malignant Mesothelioma
Lead sponsor
Augusta University
Phase
Phase 1
Overall status
Terminated
Start date
January 23, 2020
Completion date
March 28, 2022
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant mesothelioma, non small cell lung cancer, non-squamous non-small-cell lung cancer, urothelial carcinoma